Literature DB >> 23673815

Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal.

Stephanie Dellicour1, Philippe Brasseur, Per Thorn, Oumar Gaye, Piero Olliaro, Malik Badiane, Andy Stergachis, Feiko O ter Kuile.   

Abstract

BACKGROUND: There are insufficient data on the safety in early pregnancy of the artemisinins, a new class of antimalarials. Assessment of drug teratogenicity requires large sample sizes for an adequate risk-benefit assessment. There is currently limited pharmacovigilance infrastructure in malaria-endemic countries. Monitoring drug safety in early pregnancy is especially challenging, as it requires early pregnancy detection to assess any potential increased risk of miscarriage, prospective follow-up to reduce recall and survival biases, and accurate data on gestational age assessment. Record linkage approaches for pregnancy pharmacovigilance using routinely generated health records could be a pragmatic and cost-effective approach for pharmacovigilance in early pregnancy, but has not been evaluated in resource-poor settings.
OBJECTIVE: Our objective was to assess the feasibility of record linkage using routinely collected healthcare data as a pragmatic means of monitoring the safety in early pregnancy of artemisinin-based combination therapies (ACTs) in Senegal.
METHODS: Data (2004-2008) from paper-based registers from outpatient clinics, antenatal care services (ANC) and the delivery unit from the St Joseph dispensary in Mlomp, south-western Senegal, were entered into databases. Record linkage based on a probabilistic matching approach was used to identify pregnancies exposed to ACTs in the first trimester of pregnancy. Two record linkage software packages (Link-Plus and FRIL) were compared and output data were reviewed independently by two investigators.
RESULTS: Information on 685 pregnancies was extracted, 536 of which were from the geographic catchment area and eligible for record linkage; 94.6 % of them resulted in live births, 2.6 % in stillbirths and 2.8 % in miscarriages. Major congenital malformations were identified in 1.6 % of births. Seventy-three and 75 true matches between pregnancy outcome and the outpatient treatment registers were identified by two different record linkage software packages, respectively. Record linkage identified seven exposures to ACTs in the first trimester, all of which resulted in normal live-births.
CONCLUSION: Probabilistic record linkage is a potentially cost-effective method to assess the safety of antimalarials in early pregnancy in resource-constrained settings to assess increased risk of overall birth defects, and stillbirths in settings with good existing health records and well defined target populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673815     DOI: 10.1007/s40264-013-0059-1

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  20 in total

1.  Effects of malaria and its treatment in early pregnancy.

Authors:  Meghna Desai; Stephanie Dellicour
Journal:  Lancet Infect Dis       Date:  2011-12-12       Impact factor: 25.071

Review 2.  Methodological issues in the epidemiological study of the teratogenicity of drugs.

Authors:  Bengt A J Källén
Journal:  Congenit Anom (Kyoto)       Date:  2005-06       Impact factor: 1.409

Review 3.  Stillbirth rates: delivering estimates in 190 countries.

Authors:  Cynthia Stanton; Joy E Lawn; Hafiz Rahman; Katarzyna Wilczynska-Ketende; Kenneth Hill
Journal:  Lancet       Date:  2006-05-06       Impact factor: 79.321

4.  Identification of Iowa live births in the Agricultural Health Study.

Authors:  Paul A Romitti; Shinobu Watanabe-Galloway; William T Budelier; Charles F Lynch; Soman Puzhankara; Donna Wong-Gibbons; Jane A Hoppin; Michael C R Alavanja
Journal:  Arch Environ Occup Health       Date:  2010 Jul-Sep       Impact factor: 1.663

5.  Fine-grained record integration and linkage tool.

Authors:  Pawel Jurczyk; James J Lu; Li Xiong; Janet D Cragan; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-11

6.  Case-crossover and case-time-control designs in birth defects epidemiology.

Authors:  Sonia Hernández-Díaz; Miguel A Hernán; Katie Meyer; Martha M Werler; Allen A Mitchell
Journal:  Am J Epidemiol       Date:  2003-08-15       Impact factor: 4.897

7.  Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number.

Authors:  Nora Méray; Johannes B Reitsma; Anita C J Ravelli; Gouke J Bonsel
Journal:  J Clin Epidemiol       Date:  2007-05-17       Impact factor: 6.437

8.  Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.

Authors:  R McGready; S J Lee; J Wiladphaingern; E A Ashley; M J Rijken; M Boel; J A Simpson; M K Paw; M Pimanpanarak; Oh Mu; P Singhasivanon; N J White; F H Nosten
Journal:  Lancet Infect Dis       Date:  2011-12-12       Impact factor: 25.071

9.  Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.

Authors:  Piero L Olliaro; Henriette Delenne; Moustafa Cisse; Malick Badiane; Alberto Olliaro; Michel Vaillant; Philippe Brasseur
Journal:  Malar J       Date:  2008-11-07       Impact factor: 2.979

Review 10.  Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries.

Authors:  Stephanie Dellicour; Feiko O ter Kuile; Andy Stergachis
Journal:  PLoS Med       Date:  2008-09-09       Impact factor: 11.069

View more
  6 in total

1.  Validating Procedures used to Identify Duplicate Reports in Haiti's National HIV/AIDS Case Surveillance System.

Authors:  Chris Delcher; Nancy Puttkammer; Reginald Arnoux; Kesner Francois; Mark Griswold; Irum Zaidi; Yves Anthony Patrice Joseph; Barbara J Marston
Journal:  J Registry Manag       Date:  2016

2.  Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study.

Authors:  Elizabeth N Allen; Melba Gomes; Lucy Yevoo; Omar Egesah; Christine Clerk; Josaphat Byamugisha; Anthony Mbonye; Edwin Were; Ushma Mehta; Lynn M Atuyambe
Journal:  BMC Health Serv Res       Date:  2014-10-31       Impact factor: 2.655

3.  Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.

Authors:  Kerryn A Moore; Julie A Simpson; Moo Kho Paw; MuPawJay Pimanpanarak; Jacher Wiladphaingern; Marcus J Rijken; Podjanee Jittamala; Nicholas J White; Freya J I Fowkes; François Nosten; Rose McGready
Journal:  Lancet Infect Dis       Date:  2016-02-08       Impact factor: 25.071

4.  Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform.

Authors:  Dominic Mosha; Festo Mazuguni; Sigilbert Mrema; Salim Abdulla; Blaise Genton
Journal:  BMC Pregnancy Childbirth       Date:  2014-09-15       Impact factor: 3.007

5.  Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.

Authors:  Halidou Tinto; Esperança Sevene; Stephanie Dellicour; Gregory S Calip; Umberto d'Alessandro; Eusébio Macete; Seydou Nakanabo-Diallo; Adama Kazienga; Innocent Valea; Hermann Sorgho; Anifa Valá; Orvalho Augusto; Maria Ruperez; Clara Menendez; Peter Ouma; Meghna Desai; Feiko Ter Kuile; Andy Stergachis
Journal:  Reprod Health       Date:  2015-12-04       Impact factor: 3.223

Review 6.  Safety of Artemisinin Derivatives in the First Trimester of Pregnancy: A Controversial Story.

Authors:  Sarah D'Alessandro; Elena Menegola; Silvia Parapini; Donatella Taramelli; Nicoletta Basilico
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.